A detailed history of Nextech Invest Ag transactions in Arvinas, Inc. stock. As of the latest transaction made, Nextech Invest Ag holds 1,408,394 shares of ARVN stock, worth $26.9 Million. This represents 5.66% of its overall portfolio holdings.

Number of Shares
1,408,394
Previous 1,408,394 -0.0%
Holding current value
$26.9 Million
Previous $37.5 Million 7.48%
% of portfolio
5.66%
Previous 7.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$36.38 - $52.31 $10.5 Million - $15 Million
-287,251 Reduced 16.94%
1,408,394 $58.1 Million
Q4 2023

Feb 14, 2024

BUY
$14.19 - $42.33 $20 Million - $59.6 Million
1,408,394 Added 490.3%
1,695,645 $69.8 Million
Q4 2021

Feb 14, 2022

BUY
$65.85 - $96.21 $18.9 Million - $27.6 Million
287,251 New
287,251 $23.6 Million

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Nextech Invest Ag Portfolio

Follow Nextech Invest Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nextech Invest Ag, based on Form 13F filings with the SEC.

News

Stay updated on Nextech Invest Ag with notifications on news.